Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycobacterium w + Chemotherapy in Advanced NSCLC
NCT00680940Phase 2Completed
- Sponsor
- Cadila Pharmaceuticals
- Start
- Jun 2008
- Primary completion
- Dec 2010
- Modality
- Prophylactic Vaccines, Microbiome Therapeutics, Therapeutic Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of MYCIDAC-C in non-small cell lung cancer (NSCLC), sponsored by Cadila Pharmaceuticals. Started Jun 2008; status: completed.
02
Drugs
MYCIDAC-C
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00680940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00680940.